Practical and statistical considerations on simultaneous global drug development
J Biopharm Stat
.
2012 Sep;22(5):1074-7.
doi: 10.1080/10543406.2012.701588.
Authors
Ning Li
1
,
William Wang
Affiliation
1
Regulatory and Medical Policy, Sanofi, Beijing, China. ericylee1@gmail.com
PMID:
22946951
DOI:
10.1080/10543406.2012.701588
No abstract available
Publication types
Comment
MeSH terms
Data Interpretation, Statistical*
Humans
Multicenter Studies as Topic / statistics & numerical data*
Pharmacology, Clinical / statistics & numerical data*
Research Design / statistics & numerical data*
Sample Size*